Peritubular capillaries are rarefied in congenital nephrotic syndrome of the Finnish type

Kidney International

Volumn 75, Issue 10, 2009, Pages 1099-1108

  Kaukinen, Anne ^a   Lautenschlager, Irmeli ^a   Helin, Heikki ^a   Karikoski, Riitta ^a   Jalanko, Hannu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Endothelial cells; Nephrotic syndrome; NPHS1; Peritubular capillaries; Proteinuria; Tubulointerstitial microvasculature

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; P SELECTIN GLYCOPROTEIN LIGAND 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 4;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CAPILLARY DENSITY; CHILD; CLINICAL ARTICLE; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM; FIBROGENESIS; HUMAN; HUMAN TISSUE; HYPOXEMIA; INFANT; KIDNEY BLOOD VESSEL; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PERFUSION; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MESENCHYME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOSIS; TISSUE REPAIR; UPREGULATION;

EID: 67349226347     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.41     Document Type: Article

References (47)

1. KestilaM, Lenkkeri U, Manikko M et al. Positionally cloned gene for a novel glomerular protein-nephrin is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582.
2. Ruotsalainen V, Ljungberg P, Wartiovaara J et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 1999; 96: 7962-7967.
3. Patrakka J, Kestila M, Wartiovaara J et al. Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int 2000; 58: 972-980.
4. Lahdenkari A-T, Lounatmaa K, Patrakka J et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004; 15: 2911-2918.
5. Kuusniemi A-M, Lapatto R, Holmberg C et al. Kidneys with heavy proteinuria show fibrosis, inflammation and oxidative stress, but no tubular phenotypic change. Kidney Int 2005; 68: 121-132.
6. Kuusniemi A-M, Merenmies J, Lahdenkari AT et al. Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1). Kidney Int 2006; 70: 1423-1431.
7. Kaukinen A, Kuusniemi A-M, Lautenschlager I et al. Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type. Nephrol Dial Transplant 2008; 23: 1224-1232.
8. Nakagawa T, Kang DH, Ohashi R et al. Tubulointerstitial disease: role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens 2003; 12: 233-241.
9. Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int 2005; 99(Suppl): S82-S86.
10. Ivanyi B, Fahmy H, Brown H et al. Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Human Pathol 2000; 31: 1129-1138.
11. Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 2000; 11: 47-56.
12. Kang DH, Kanellis J, Hugo C et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806-816.
13. Rabelink TJ, Wijewickrama DC, de Koning EJ. Peritubular endothelium: the Achilles heel of the kidney. Kidney Int 2007; 72: 926-930.
14. Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 2006; 33: 989-996.
15. Eddy AA. Can renal fibrosis be reversed? Pediatr Nephrol 2005; 20: 1396-1475.
16. Choi YJ, Chakraborty S, Nguyen V et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Human Pathol 2000; 31: 1491-1497.
17. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
18. Nangaku M. Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp nephrology 2004; 98: e8-e12.
19. Shu Y, Hoshi S, Tomari S et al. Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis. Pathol Int 2002; 52: 214-223.
20. Gandhi M, Olson JL, Meyer TW. Contribution of tubular injury to loss of remnant kidney function. Kidney Int 1998; 54: 1157-1165.
21. Benigni A, Gagliardini E, Remuzzi A et al. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist. Am J Pathol 2001; 159: 1743-1750.
22. Basile DP. Rarefication of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 2004; 13: 1-7.
23. Ishii Y, Sawada T, Kubota K et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 2005; 67: 321-332.
24. Muchaneta-Kubara EC, El Nahas AM. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997; 12: 904-915.
25. Manotham K, Tanaka T, Matsumoto M et al. Transdifferentation of cultured tubular cells induced by hypoxia. Kidney Int 2004; 65: 871-880.
26. Simonson MS. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int 2007; 71: 846-854.
27. O'Riordan E, Mendelev N, Patschan S et al. Chronic NOS inhibition actuates endothelial-mesenchymal transition. Am J Physiol Heart Circ Physiol 2007; 292: H285-H294.
28. Sanai T, Sobka T, Johnson T et al. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia 2000; 43: 91-100.
29. Suzuki T, Kimura M, Asano M et al. Role of atrophic tubules in development of interstitial fibrosis in microembolism-induced renal failure in rat. Am J Pathol 2001; 158: 75-80.
30. Hertig A, Anglicheau D, Verine J et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008; 23: 1-8.
31. de Zeeuw D, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309-2320.
32. Tarver-Carr M, Brancati F, Eberhardt MS et al. Proteinuria and the risk of chronic kidney disease (CDK) in the United States. J Am Soc Nephrol 2000; 11: 168A.
33. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17: 2974-2984.
34. Wong MG, Suzuki Y, Tanifuji C et al. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. J Am Soc Nephrol 2008; 19: 290-297.
35. Steeber DA, Guglielmo M, Venturi F et al. A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol 2005; 26: 9-12.
36. Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vascul Pharmacol 2007; 46: 229-237.
37. Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc Nephrol 2006; 17: S145-S147.
38. Kakkar AK, Lefer DJ. Leukocyte and endothelial adhesion molecule studies in knockout mice. Curr Opin Pharmacol 2004; 4: 154-158.
39. Hordijk PL. Endothelial signalling events during leukocyte transmigration. FEBS J 2006; 273: 4408-4415.
40. Muller GA, Markovic-Lipkovski J, Muller CA. Intercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis. Clin Nephrol 1991; 36: 203-208.
41. Dal Canton A, Fuiano G, Sepe V et al. Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis. Kidney Int 1992; 41: 951-955.
42. Wuthrich RP, Jevnikar AM, Takei F et al. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol 1990; 136: 441-450.
43. Seron D, Cameron JS, Haskard DO. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 1991; 6: 917-922.
44. Reinders MEJ, Rabelink TJ, Briscoe DM. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 2006; 17: 932-942.
45. Mettouchi A, Meneguzzi G. Distinct roles of b1 integrins during angiogenesis. Eur J Cell Biol 2006; 85: 243-247.
46. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004; 65: 2003-2017.
47. Lindenmeyer MT, Kretzler M, Boucherot A et al. Interstitial vascular rarefication and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776.